212 related articles for article (PubMed ID: 33458760)
1. Significant decline in the prevalence of Barrett's esophagus among patients with gastroesophageal reflux disease.
Hamade N; Weng G; Desai M; Chandrasekar VT; Dasari C; Kennedy K; Sharma P
Dis Esophagus; 2021 May; 34(5):. PubMed ID: 33458760
[TBL] [Abstract][Full Text] [Related]
2. Prevalence and predictors of columnar lined esophagus in gastroesophageal reflux disease (GERD) patients undergoing upper endoscopy.
Balasubramanian G; Singh M; Gupta N; Gaddam S; Giacchino M; Wani SB; Moloney B; Higbee AD; Rastogi A; Bansal A; Sharma P
Am J Gastroenterol; 2012 Nov; 107(11):1655-61. PubMed ID: 23032983
[TBL] [Abstract][Full Text] [Related]
3. LOW PREVALENCE OF BARRETT'S ESOPHAGUS IN A RISK AREA FOR ESOPHAGEAL CANCER IN SOUTH OF BRAZIL.
DE Carli DM; Araujo AF; Fagundes RB
Arq Gastroenterol; 2017 Dec; 54(4):305-307. PubMed ID: 28954045
[TBL] [Abstract][Full Text] [Related]
4. The frequency of Barrett's esophagus in high-risk patients with chronic GERD.
Westhoff B; Brotze S; Weston A; McElhinney C; Cherian R; Mayo MS; Smith HJ; Sharma P
Gastrointest Endosc; 2005 Feb; 61(2):226-31. PubMed ID: 15729230
[TBL] [Abstract][Full Text] [Related]
5. Laryngopharyngeal reflux symptoms better predict the presence of esophageal adenocarcinoma than typical gastroesophageal reflux symptoms.
Reavis KM; Morris CD; Gopal DV; Hunter JG; Jobe BA
Ann Surg; 2004 Jun; 239(6):849-56; discussion 856-8. PubMed ID: 15166964
[TBL] [Abstract][Full Text] [Related]
6. Incomplete Response of Gastroesophageal Reflux Symptoms Poorly Predicts Erosive Esophagitis or Barrett's Esophagus.
Rubenstein JH; Jiang L; Kurlander JE; Chen J; Metko V; Khodadost M; Nofz K; Raghunathan T
Clin Gastroenterol Hepatol; 2021 Nov; 19(11):2284-2292.e2. PubMed ID: 32835843
[TBL] [Abstract][Full Text] [Related]
7. Risk factors for nocturnal reflux in a large GERD cohort.
Gaddam S; Maddur H; Wani S; Gupta N; Singh M; Singh V; Moloney B; Puli SR; Rastogi A; Bansal A; Sharma P
J Clin Gastroenterol; 2011 Oct; 45(9):764-8. PubMed ID: 21633310
[TBL] [Abstract][Full Text] [Related]
8. Gastroesophageal reflux disease, proton-pump inhibitor use and Barrett's esophagus in esophageal adenocarcinoma: Trends revisited.
Lada MJ; Nieman DR; Han M; Timratana P; Alsalahi O; Peyre CG; Jones CE; Watson TJ; Peters JH
Surgery; 2013 Oct; 154(4):856-64; discussion 864-6. PubMed ID: 24074425
[TBL] [Abstract][Full Text] [Related]
9. Risk factors in the development of esophageal adenocarcinoma.
Pohl H; Wrobel K; Bojarski C; Voderholzer W; Sonnenberg A; Rösch T; Baumgart DC
Am J Gastroenterol; 2013 Feb; 108(2):200-7. PubMed ID: 23247577
[TBL] [Abstract][Full Text] [Related]
10. Multimodality evaluation of patients with gastroesophageal reflux disease symptoms who have failed empiric proton pump inhibitor therapy.
Galindo G; Vassalle J; Marcus SN; Triadafilopoulos G
Dis Esophagus; 2013 Jul; 26(5):443-50. PubMed ID: 22862422
[TBL] [Abstract][Full Text] [Related]
11. Clinical and demographic predictors of Barrett's esophagus among patients with gastroesophageal reflux disease: a multivariable analysis in veterans.
Eloubeidi MA; Provenzale D
J Clin Gastroenterol; 2001 Oct; 33(4):306-9. PubMed ID: 11588545
[TBL] [Abstract][Full Text] [Related]
12. [The influence of Barrett's esophagus on the clinical signs and postoperative results of GERD].
Endzinas Z; Mickevicius A; Kiudelis M
Zentralbl Chir; 2004 Apr; 129(2):99-103. PubMed ID: 15106039
[TBL] [Abstract][Full Text] [Related]
13. Gastroesophageal reflux disease and Barrett's esophagus after laparoscopic sleeve gastrectomy: a possible, underestimated long-term complication.
Genco A; Soricelli E; Casella G; Maselli R; Castagneto-Gissey L; Di Lorenzo N; Basso N
Surg Obes Relat Dis; 2017 Apr; 13(4):568-574. PubMed ID: 28089434
[TBL] [Abstract][Full Text] [Related]
14. Gastroesophageal reflux disease: prevalence, clinical, endoscopic and histopathological findings in 1,128 consecutive patients referred for endoscopy due to dyspeptic and reflux symptoms.
Voutilainen M; Sipponen P; Mecklin JP; Juhola M; Färkkilä M
Digestion; 2000; 61(1):6-13. PubMed ID: 10671769
[TBL] [Abstract][Full Text] [Related]
15. Nighttime heartburn in patients with gastroesophageal reflux disease under routine care.
Nocon M; Labenz J; Jaspersen D; Leodolter A; Meyer-Sabellek W; Stolte M; Vieth M; Lind T; Malfertheiner P; Willich SN
Digestion; 2008; 77(2):69-72. PubMed ID: 18349541
[TBL] [Abstract][Full Text] [Related]
16. Recent advances in oesophageal diseases.
Al Dulaimi D
Gastroenterol Hepatol Bed Bench; 2014; 7(3):186-9. PubMed ID: 25120902
[TBL] [Abstract][Full Text] [Related]
17. Leukocyte telomere length in relation to the risk of Barrett's esophagus and esophageal adenocarcinoma.
Wennerström EC; Risques RA; Prunkard D; Giffen C; Corley DA; Murray LJ; Whiteman DC; Wu AH; Bernstein L; Ye W; Chow WH; Vaughan TL; Liao LM
Cancer Med; 2016 Sep; 5(9):2657-65. PubMed ID: 27384379
[TBL] [Abstract][Full Text] [Related]
18. Barrett's Esophagus: A Comparison Study between Two Cohorts of Gastroesophageal Reflux Disease.
Devadas K; George B; Varghese J; Hareendran A; Nahaz N; Oommen TT; Joseph RC; Narayanan V
J Assoc Physicians India; 2022 Oct; 70(10):11-12. PubMed ID: 37355861
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of Barrett's esophagus in patients with or without GERD symptoms: role of race, age, and gender.
Fan X; Snyder N
Dig Dis Sci; 2009 Mar; 54(3):572-7. PubMed ID: 18654849
[TBL] [Abstract][Full Text] [Related]
20. Features of symptomatic gastroesophageal reflux disease in elderly patients.
Triadafilopoulos G; Sharma R
Am J Gastroenterol; 1997 Nov; 92(11):2007-11. PubMed ID: 9362181
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
